Cancer Immunotherapy Drug Discovery Outsourcing Market (By Drug type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines, Others; By Cancer type - Target Identification and Validation, Lead Screening and Characterization, Cell Based Assays; By Service type - HealtLung, Breast, Colorectal, Melanoma, Prostate, Head and Neck, Ovarian, Pancreatic) - Global Industry Size, Share, Trends and Forecast 2018-2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 180

Introduction

The global cancer immunotherapy drug discovery outsourcingmarket is project worth $1.8 Billion in 2026 and the market is projected to showcase 14.0% CAGR during the forecast period. The market is driven by increasing cancer patients and surging awareness about developments and improvement in cancer immunotherapy.

Market Dynamics

Increase in occurrence of cancer disease and increasing mortality associated with cancer are the key reasons for the growth of the cancer immunotherapy drug discovery outsourcing market. Furthermore, supportive government regulation for healthcare sector is optimistically impacting the development of the market and is anticipated to drive the development during the forecast period.

Increasing number of cancer patients across the world drive the demand for better cancer treatment and diagnostics services globally during the forecast period. Also, Pharmaceutical businesses are concentrating on immunotherapies subsequently they are a potential treatment alternative for cancer due to their capability to shrink the risk of post chemotherapy tumor reoccurrence.

Furthermore, favourable tax credit permits pharmaceutical businesses to properly plan their global projects with a reputed CRO, which will help in them in growing their business and avoiding taxation related problems. This factor also contribute in the growth of the market.

Market Insights

The global cancer immunotherapy drug discovery outsourcingmarket is anticipated to account the substantial growth in the coming years, attributed to increasing alertness and awareness about developments in cancer immunotherapy paired with growing investments by pharmaceutical businesses in outsourcing and subcontracting is anticipated to boost in the growth of thecancer immunotherapy drug discovery outsourcing market.

Market Classification

The global cancer immunotherapy drug discovery outsourcing market is segmented into four major segment named drug type, service type, cancer type, and region. On the basis of drug type the cancer immunotherapy drug discovery outsourcing market is segmented intomonoclonal antibodies, immunomodulators, oncolytic viral therapies and cancer vaccines, and others. On the basis of the service type the global cancer immunotherapy drug discovery outsourcing market is segmented into target identification and validation, lead screening and characterization and cell based assays.On the basis of cancer type, the cancer immunotherapy drug discovery outsourcing market is segmented into lung, breast, colorectal, melanoma, prostate, head and neck, ovarian and pancreatic. On the basis of region the global Cancer Immunotherapy Drug Discovery Outsourcing market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Regional Insights

In 2018, North America accounts largest revenue share and the region is anticipated to continue its dominance over the forecast period as the region has domicile of big pharmaceutical giants. Other reason for the growth of the North America cancer immunotherapy drug discovery outsourcing market are high per capita healthcare expenditure, and increasing awareness about the canner treatment and diagnostic system.

Europe is anticipated to be the second fastest-developing market for cancer immunotherapy drug discovery outsourcing. Increased incidence of cancer diseases and occurrence of a huge target population base are the crucial factors growing demand for cancer immunotherapy drug discovery outsourcingin the region.

Report Coverage

Market

Cancer Immunotherapy Drug Discovery OutsourcingMarket

Analysis Period

2016– 2026

Historic Data

2016 – 2017

Base Year

2018

Forecast Data

2019 – 2026

Market Stratification

Drug type, Service type, Cancer typeand Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis

Market Participants

The major players associated with the cancer immunotherapy drug discovery outsourcing market Aquila BioMedical,Crown Bioscience, Inc.,Molecular Imaging, Inc.,Explicyte,Horizon Discovery Group PLC,STC Biologics,Promega Corporation,Personalis, Inc.,HD Biosciences Co.,DiscoverX Corporation,Genscript Biotech Corporation,BPS Bioscience, Inc.,ImmunXperts SA, andCelentyx Ltd.

Market Segmentation

Market ByDrug type

  • Monoclonal Antibodies
  • Immunomodulators
  • Oncolytic Viral Therapies and Cancer Vaccines
  • Others

Market ByCancer type

  • Target Identification and Validation
  • Lead Screening and Characterization
  • Cell Based Assays

Market ByService type

  • HealtLung
  • Breast
  • Colorectal
  • Melanoma
  • Prostate
  • Head and Neck
  • Ovarian
  • Pancreatic

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

 


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary